Skip to main content
. 2021 Mar 25;31(2):114–125. doi: 10.1089/nat.2020.0879

Table 3.

Classes of Oligonucleotide Therapeutics

  Structure Target Binding Action
Antisense Single-stranded DNA (generally including chemically modified nucleic acids; relatively short strands) mRNA pre-mRNA miRNA Sequence-specific binding to RNA Inhibition of translation, control of splicing
siRNA Double-stranded RNA (sometimes including chemically modified nucleic acids; relatively short strands) mRNA Sequence-specific binding to RNA mRNA cleavage, inhibition of translation
miRNA Double-stranded RNA (relatively short strands) mRNA Sequence-specific binding to RNA Control of translation
Decoy Double-stranded DNA (relatively short strands) Transcription factor Binding to transcription factor Inhibition of transcription
Aptamer Single-stranded DNA or RNA (sometimes including chemically modified nucleic acids; relatively long strands) Protein Binding to target molecule Antibody-like effects

miRNA, microRNA.